Articles On Proteomics International Laboratories (ASX:PIQ)

Proteomics International (PIQ) is awarded over $400,000 in funding to manufacture its predictive diagnostic test for diabetic kidney disease The company receives the funds from MTPConnect to develop its PromarkerD clinical diagnostic test...

Proteomics International establishes world class Clinical Advisory Board promarkerd.com/clinical-advisory-board Comprises highly-respected physicians specialising in diabetes and kidney disease care from the United States, Europe and...

Chimeric wants to accelerate its clinical trial readiness via a deal with WuXi Recce advances to higher dosing in Phase I clinical trial Proteomics engages experts to advance commercialisation Chimeric signs deal with WuXi Cell therapy sp...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Here’s something for anyone who...

The ASX 200 Health Index (XHJ) and the benchmark ASX 200 are trading flat today. Proteomics advances on blood test results Investors gave Proteomics International Laboratories (ASX:PIQ) the thumbs up after the company said it has identified...

Proteomics International Laboratories (PIQ) completes a study targeting oesophageal adenocarcinoma cancer Proteomics International and QIMR Berghofer are collaborating on the development of a simple blood test for oesophageal adenocarcinom...

ASX to fall as Meta crash derails Tech rebound Local shares are expected to open lower this morning as a Meta (née Facebook) crash overnight derailed the Wall Street rebound. Meta plunged by 26% after reporting a decline in daily active use...

The ASX 200 Health Index (XHJ) has dropped by almost 5% at the time of writing, compared to the broader index which is down by 0.20%. Healthcare giant and blood specialist, CSL (ASX:CSL), which makes up a large part of the ASX Healthcare in...

Wall Street rallies on Fed decision US stocks rallied strongly overnight, as investors digested the central bank’s decision to speed up its tapering program and hike rates next year. Fed Reserve governor Jerome Powell said the bank will red...

Proteomics International Laboratories (PIQ) sees its cash reserves strengthened by a $1.2 million research and development tax incentive for the 2020/2021 financial year During FY21 Proteomics spent $2.85 million on R&D, enabling the c...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

World’s first predictive diagnostic test for diabetic kidney disease to be sold in Great Britain under distribution deal with global diagnostic distributor, Apacor Limited Apacor will become the exclusive distributor for PromarkerD...

Proteomics International Laboratories (PIQ) signs a deal with medical diagnostics company Apacor to bring its PromarketD test to Britain PromarkerD is a biomarker-based blood test that predicts kidney function decline in type 2 diabetes Th...

Study shows PromarkerD is significantly better than current standard of care tests eGFR and ACR for predicting future decline in kidney function in patients with type 2 diabetes PromarkerD correctly identified 84% of patients with n...

Wall Street sets record highs for fifth consecutive day US stocks closed their fifth consecutive day at all time highs, as weekly jobless claims continue to head in the right direction. The S&P 500 rose by 0.42% and the Nasdaq was up 0....

Proteomics International Laboratories (PIQ) says study results show PromarkerD is superior to the current standard of care tests for predicting future kidney function decline in type 2 diabetes The company says its trial of 850 patients de...

Proteomics International Laboratories (PIQ) has been awarded a $100,000 voucher to manufacture clinical diagnostic tests in Western Australia The funding from the MTPConnect WA Life Sciences Innovation Hub MTP will go towards producing Pro...

It’s been a busy morning for the ASX Healthcare sector, with plenty of positive announcements for investors to digest. But the Health Index (XHJ) is trading down by 0.5% at the time of writing, compared to the broader index which is trading...

BRISBANE, Australia, Aug. 12, 2021 /PRNewswire/ — Treatment with diabetes drug canagliflozin lowers the PromarkerD risk score for developing diabetic kidney disease in patients with type 2 diabetes, latest research suggests. In a study pres...

Summary  The Australian benchmark index, ASX200, added 4 points to close at fresh closing high of 7,588. The index gained as much as 0.3% to hit an intraday high of 7,608.6 during the session.  Agro-based company GrainCorp topped the...

Proteomics International Laboratories (ASX:PIQ) has announced it has contracted French immunoassay specialist Biotem to manufacture test kits for the PromarkerD predictive test for diabetic kidney disease.

Summary REA Group (ASX:REA) completes transaction with PropertyGuru BNK Banking (ASX:BBC) announces alliance with Goldman Sachs for A$500m Securitisation Warehouse Westpac (ASX:WBC) to kick-off jab program for Western Sydney The S...

Summary Benchmark index, the ASX 200, hit a record high of 7,509.2 this morning. The market was supported by gains in blue-chip miners BHP and Rio, as well as banking majors. Seven of 11 sectors traded in green, while material and ene...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

Australian shares have extended gains for the second day in a row, rising by 0.91% despite more COVID cases across states. All 11 sectors were in the green, except for Healthcare. Mining and Energy led the gains, rising by 2% each, buoyed b...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

Proteomics International Laboratories says a retrospective study has found diabetes patients using treatment drug, canagliflozin, returned scores indicating they were statistically at lower risk of developing kidney disease by using Proteom...

The Proteomics International Laboratories Ltd (ASX: PIQ) share price has jumped firmly into the green today. Shares in the Australian biotech company surged this morning and jumped 10% from the market open, before retreating back down. At...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

The Proteomics International Laboratories Ltd (ASX: PIQ) share price won’t be going anywhere today. Shares in the biotech company were placed in a trading halt late yesterday. Let’s take a look at why the company’s shares are at a halt and...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Theme of the week Healthcare fi...

Australian shares appeared to shrug off the latest COVID-19 lockdowns for much of the day, but ultimately closed lower on the day. The ASX200 finished 0.01 per cent down at 7,307, while the ASX Emerging Companies Index fell 1.22 per cent, c...

Around 1 million residents of some inner-Sydney suburbs are to stay at home until next Friday, after the latest government-imposed lockdown. The restrictions will begin at midnight today, and last until midnight on Friday, July 2. To market...

Proteomics International Laboratories says independent research on its “ground-breaking” PromarkerD test for diagnosis of kidney disease in diabetes sufferers suggests the test could improve quality of care and save US care services payers...

Wall Street climbs on Biden stimulus All three major US benchmarks rose on Thursday, as President Biden announced a US$579 billion stimulus. The Dow Jones rose by 0.95%, S&P 500 by 0.58%, and tech-heavy Nasdaq hit another record, rising...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week As we appro...

Proteomics International Laboratories (ASX:PIQ) has announced the expansion of its executive team with the appointments of Vik Malik as its new chief commercialisation officer (CCO) and Jacqueline Gray as its new chief financial off...

Ask a Fund Manager The Motley Fool chats with fund managers so that you can get an insight into how the professionals think. In Part 2 of this edition, Kardinia Capital’s portfolio manager Kristiaan Rehder reveals 2 small-cap ASX shares wi...

Summary Oncology firm Telix Pharmaceuticals has entered into an exclusive commercial distribution agreement to distribute its product in the German market. Proteomics has secured a significant contract for pharmacokinetic testing, whil...

Medical technology group, Proteomics International Laboratories has picked up an analytical services contract in pharmacokinetic testing worth $243,000 with leading clinical trial contract research organisation, Avance Clinical. Perth-based...

A series of ASX announcements has attracted investors to the biotech sector today, lifting the share prices of some of its players. The buying frenzy has also lifted the broader health sector by as high as 1 per cent earlier today, but is c...

Summary Telix Pharmaceuticals signs distribution agreement with Germany based company Proteomics International bags new pharmacokinetic testing contract com accomplishes A$428 million institutional entitlement offer Citi hikes PT for...

US and European stock markets down to start the week All major indices in US and Europe were down on Monday, after Covid cases spiked in some parts of the world. The Dow Jones was down 0.16%, S&P 500 fell 0.25%, and tech heavy NASDAQ dr...

Medical technology group, Proteomics International Laboratories says an economic health benefit study suggests its PromarkerD test for diabetic kidney disease has the potential to save Americans suffering from type 2 diabetes billions of do...

Sell-off on Wall Street after inflation rose to highest since 2009 All major indices in US tumbled after US consumer price increased by 0.8% in April, climbing by the most since 2009 and topping estimates. The steeper than expected inflatio...

After flying 5% higher this morning, it was downhill all the way for the Proteomics International Laboratories Ltd (ASX: PIQ) share price today. At the market close today, shares in the medical technology company were right back where they...

Proteomics International Laboratories has received an ISO 13485 certification, which it describes as the most widely used international standard for quality management systems in the manufacture of medical devices. It says the certification...

ASX-listed medical technology company, Proteomics International Laboratories’ coffers have been further boosted by a $1.1 million research and development tax rebate following a recent successful capital raise of $6 million.

ASX-listed medical technology company, Proteomics International Laboratories, has locked away $6m in cash via a heavily oversubscribed placement to UK-based and local institutions and other sophisticated investors, to progress the marketing...